戻る
「早戻しボタン」を押すと検索画面に戻ります。 [閉じる]

コーパス検索結果 (1語後でソート)

通し番号をクリックするとPubMedの該当ページを表示します
1  humans, rather than endogenous mTERT (mouse telomerase reverse transcriptase).
2 erase RNA; hTER) and the core protein (human telomerase reverse transcriptase).
3 ) decreases the mRNA expression of the human telomerase reverse transcriptase.
4 the MRP ribonucleoprotein ribozyme and human telomerase reverse transcriptase.
5 form stable complexes with the TEN domain of telomerase reverse transcriptase.
6 higher-order multimers of telomerase RNA and telomerase reverse transcriptase.
7 -circle formation in normal cells expressing telomerase reverse transcriptase.
8 he synthesis of the telomeric repeats by the telomerase reverse transcriptase.
9 and T-motif in the RNA-binding domain of the telomerase reverse transcriptase.
10 f two genes, asparagine synthetase and human telomerase reverse transcriptase.
11 nds to a peptide sequence derived from human telomerase reverse transcriptase.
12 tative polymerase chain reaction using human telomerase reverse transcriptase.
13 otide that targets the RNA template of human telomerase reverse transcriptase.
14        The templating RNA is the core of the telomerase reverse transcriptase.
15 and P6.1 to correctly fold and interact with telomerase reverse transcriptase.
16 nts with heterozygous mutations in TERT, the telomerase reverse transcriptase, a 50% reduction in tel
17 ligo also inhibited mRNA expression of human telomerase reverse transcriptase, a catalytic subunit of
18                                          The telomerase reverse transcriptase adds de novo DNA repeat
19 n Atm(-/-) mice engineered with an inducible telomerase reverse transcriptase allele.
20     Telomerases from all organisms contain a telomerase reverse transcriptase and a telomerase RNA (T
21 oblasts transduced with genes encoding human telomerase reverse transcriptase and doxycycline-inducib
22 rmore, we showed that reducing expression of telomerase reverse transcriptase and telomerase activity
23                             Mutations in the telomerase reverse transcriptase and telomerase RNA comp
24 tations in the genes hTERT and hTR, encoding telomerase reverse transcriptase and telomerase RNA, res
25 ikely to change conformation in complex with telomerase reverse transcriptase and that it provides a
26 tumor antigen vaccine derived from the human telomerase reverse transcriptase and the antiapoptotic p
27  the former encodes the catalytic subunit of telomerase reverse transcriptase and the latter may play
28                          Thus, p43 joins the telomerase reverse transcriptase and the yeast proteins
29 nent and the N-terminally biotinylated human telomerase reverse transcriptase and using a newly devel
30 riction decreased expression of hTERT (human telomerase reverse transcriptase) and increased expressi
31  expressed higher levels of K5, CD133, Oct4, telomerase reverse transcriptase, and C-X-C chemokine li
32 iched for expression of Ki-67, ZAP-70, human telomerase reverse transcriptase, and telomerase activit
33 ry, these data suggest that cells expressing telomerase reverse transcriptase are not a progenitor-ce
34 tension (CTE) domain of Arabidopsis thaliana telomerase reverse transcriptase as baits to screen an A
35 d beta1 integrins, DeltaNp63alpha, CD44, and telomerase reverse transcriptase, as well as decreased N
36 ted from chimera mice expressed collagen and telomerase reverse transcriptase but not alpha-smooth mu
37 n) were identified in TERT, the gene for the telomerase reverse transcriptase catalytic enzyme, among
38 ertion in fingers domain" (IFD) in the human telomerase reverse transcriptase catalytic subunit (hTER
39 ll-known "telomere disorder." RMRP binds the telomerase reverse transcriptase (catalytic subunit) in
40 ular and cytogenetic features of the chicken telomerase reverse transcriptase (chTERT) gene and prote
41  it is quickly silenced, specifically due to telomerase reverse transcriptase component (TERT) down-r
42 use myocardium, and transgenic expression of telomerase reverse transcriptase conferred protection fr
43 lmonary fibrosis by activation of fibroblast telomerase reverse transcriptase-dependent proliferation
44  for malignant behavior, expression of human telomerase reverse transcriptase enabled cells from seri
45 lls, whereas interleukin-31 strongly induced telomerase reverse transcriptase expression in fibroblas
46 report that BRCA1 knockdown causes increased telomerase reverse transcriptase expression, telomerase
47              The organization of the t/PK on telomerase reverse transcriptase for medaka and human is
48 ss various N-terminal fusion proteins of the telomerase reverse transcriptase from its endogenous loc
49 f renal tumor-associated antigens, including telomerase reverse transcriptase, G250, and oncofetal an
50 -Myc can activate transcription of the human telomerase reverse transcriptase gene (hTERT), we addres
51 oted c-Myc-dependent expression of the human telomerase reverse transcriptase gene (hTERT).
52 e hotspot integrations, such as those in the telomerase reverse transcriptase gene (TERT) promoter, a
53 ty, which is accompanied by induction of the telomerase reverse transcriptase gene (TERT).
54 hromosomal region at 5p15.33 proximal of the telomerase reverse transcriptase gene (TERT).
55 ecruited by Myc to the promoter of the human telomerase reverse transcriptase gene, and p300/CBP stim
56 mice was not affected by inactivation of the telomerase reverse transcriptase gene, indicating that e
57 ome clone containing the entire hTERT (human telomerase reverse transcriptase) gene was introduced in
58 in TERC (telomerase RNA component) and TERT (telomerase reverse transcriptase) have been found in aut
59     When Fancc(-/-) mice were crossed into a telomerase reverse transcriptase heterozygous or null ba
60                                    The human telomerase reverse transcriptase hTERT is highly express
61 therapy, the immunological properties of the telomerase reverse transcriptase hTERT suggest that the
62              Here, we demonstrate that human telomerase reverse transcriptase (hTERT) activates vascu
63 the core components of telomerase, the human telomerase reverse transcriptase (hTERT) and associated
64 dopts a new conformation on binding to human telomerase reverse transcriptase (hTERT) and reconstitut
65 LA-DR-restricted peptides derived from human telomerase reverse transcriptase (hTERT) and referred as
66                   Higher expression of human telomerase reverse transcriptase (hTERT) and subsequent
67 , the cells were exposed to retroviral human telomerase reverse transcriptase (hTERT) and/or SV40 lar
68                    Mutations in the gene for telomerase reverse transcriptase (hTERT) are associated
69 S signaling pathways and activation of human telomerase reverse transcriptase (hTERT) are common in h
70  expression and telomerase activity of human telomerase reverse transcriptase (hTERT) are hallmarks o
71    The mRNA and promoter activities of human telomerase reverse transcriptase (hTERT) are stimulated
72                          Expression of human telomerase reverse transcriptase (hTERT) catalytic subun
73 lects E6-enhanced transcription of the human telomerase reverse transcriptase (hTERT) catalytic subun
74 ce mechanism, ALT+ human fibroblasts require telomerase reverse transcriptase (hTERT) for tumor forma
75  optical methods to measure changes in human telomerase reverse transcriptase (hTERT) gene expression
76                         The endogenous human telomerase reverse transcriptase (hTERT) gene is repress
77                                    The human telomerase reverse transcriptase (hTERT) gene is repress
78 s to and regulates the activity of the human telomerase reverse transcriptase (hTERT) gene promoter.
79 e ectopic expression of telomerase via human telomerase reverse transcriptase (hTERT) gene transfecti
80 so by transcriptionally activating the human telomerase reverse transcriptase (hTERT) gene, which enc
81      Transcriptional activation of the human telomerase reverse transcriptase (hTERT) gene, which rem
82 BV and three HPV integrations into the human telomerase reverse transcriptase (hTERT) gene.
83  G-quadruplexes in the promoter of the human telomerase reverse transcriptase (hTERT) gene.
84  increased mRNA expression of CSF1R in human telomerase reverse transcriptase (hTERT) immortalized hu
85 of endogenous human telomerase RNA (hTR) and telomerase reverse transcriptase (hTERT) in HeLa cervica
86 in reaction (RT-PCR) for expression of human telomerase reverse transcriptase (hTERT) in mediastinal
87 to knock down factors cooperating with human telomerase reverse transcriptase (hTERT) in the immortal
88 onal conversion, whereas expression of human telomerase reverse transcriptase (hTERT) induces it.
89                                        Human telomerase reverse transcriptase (hTERT) is also often o
90      The transcriptional activation of human telomerase reverse transcriptase (hTERT) is an important
91 mechanisms governing expression of the human telomerase reverse transcriptase (hTERT) is important fo
92                                        Human telomerase reverse transcriptase (hTERT) is localized to
93                                    The human telomerase reverse transcriptase (hTERT) is nearly unive
94                                        Human telomerase reverse transcriptase (hTERT) is overexpresse
95                                        Human telomerase reverse transcriptase (hTERT) is overexpresse
96 s of the active full-length isoform of human telomerase reverse transcriptase (hTERT) may be expresse
97  analyses showed that leptin increased human telomerase reverse transcriptase (hTERT) mRNA expression
98     Although Tax impaired induction of human telomerase reverse transcriptase (hTERT) mRNA in respons
99 ,25(OH)(2)VD(3) decreases the level of human telomerase reverse transcriptase (hTERT) mRNA, the catal
100                                        Human telomerase reverse transcriptase (hTERT) plays a key rol
101  to show that FTSECs immortalized with human telomerase reverse transcriptase (hTERT) plus SV40 large
102 sid for enhanced tumor transduction, a human telomerase reverse transcriptase (hTERT) promoter for tu
103                                    The human telomerase reverse transcriptase (hTERT) promoter has be
104 s in the regulation of the activity of human telomerase reverse transcriptase (hTERT) promoter in res
105 al system, we recently showed that the human telomerase reverse transcriptase (hTERT) promoter induce
106 tly demonstrated that E6 activates the human telomerase reverse transcriptase (hTERT) promoter via a
107 l replication, is under control of the human telomerase reverse transcriptase (hTERT) promoter.
108                                              Telomerase reverse transcriptase (hTERT) represents an a
109 ing network consistent with a model of human telomerase reverse transcriptase (hTERT) repression in A
110 unction mutations in the TEN-domain of human telomerase reverse transcriptase (hTERT) that disrupt th
111 expressed transcriptional regulator of human telomerase reverse transcriptase (hTERT) that is targete
112  established that hTR remains bound to human telomerase reverse transcriptase (hTERT) throughout all
113 a gene (pRb) and ectopic expression of human telomerase reverse transcriptase (hTERT) to immortalize
114 e we used retroviral overexpression of human telomerase reverse transcriptase (hTERT) to immortalize
115                        Upregulation of human telomerase reverse transcriptase (hTERT) transcription a
116  of Bmi-1 in MECs led to activation of human telomerase reverse transcriptase (hTERT) transcription a
117                                    The human telomerase reverse transcriptase (hTERT) utilizes a temp
118 atalytic component of human telomerase human telomerase reverse transcriptase (hTERT), and colonies w
119  of p53, transcriptional activation of human telomerase reverse transcriptase (hTERT), and degradatio
120 f human telomerase, telomerase RNA (hTR) and telomerase reverse transcriptase (hTERT), are recruited
121 iated by the induced overexpression of human telomerase reverse transcriptase (hTERT), has permitted
122   The catalytic subunit of telomerase, human telomerase reverse transcriptase (hTERT), is overexpress
123 ng cyclin-dependent kinase (Cdk) 4 and human telomerase reverse transcriptase (hTERT), resulting in c
124 nk between HMGA2 and the regulation of human telomerase reverse transcriptase (hTERT), the catalytic
125                                        Human telomerase reverse transcriptase (hTERT), the catalytic
126 h the transcription and translation of human telomerase reverse transcriptase (hTERT), the catalytic
127    We present evidence that normal and human telomerase reverse transcriptase (hTERT)-immortalized hu
128   Here we characterize the response of human telomerase reverse transcriptase (hTERT)-immortalized no
129                      We show here that human telomerase reverse transcriptase (hTERT)-immortalized pr
130 ressor pathways in NHUC and to express human telomerase reverse transcriptase (hTERT).
131 cted with a retroviral vector encoding human telomerase reverse transcriptase (hTERT).
132 e expression of its enzymatic subunit, human telomerase reverse transcriptase (hTERT).
133 or telomere synthesis, which is catalyzed by telomerase reverse transcriptase (hTERT).
134 rmal human fibroblast (NHF) expressing human telomerase reverse transcriptase (hTERT).
135 onents, human telomerase RNA (hTR) and human telomerase reverse transcriptase (hTERT).
136  induction of the telomerase component human telomerase reverse transcriptase (hTERT); T cell activat
137 ein catalytic component of telomerase [human telomerase reverse transcriptase (hTERT)] are required f
138 n of the telomerase catalytic subunit [human telomerase reverse transcriptase (hTERT)] expression abr
139                                        Human telomerase reverse transcriptase (hTERT; the catalytic p
140 is the transcriptional upregulation of human telomerase reverse transcriptase, hTERT, and the resulta
141 n of the telomerase catalytic subunit (human telomerase reverse transcriptase; hTERT) in human activa
142                                        Human telomerase reverse transcriptase (hTRT) is preferentiall
143 1delta) blocks primary ciliogenesis in human telomerase reverse transcriptase immortalized retinal pi
144 orm of CDK4 or knockdown of p16 in the human telomerase reverse transcriptase-immortalized NPE cell l
145                                     In human telomerase reverse transcriptase-immortalized NPE cells,
146 n of TRF2 expression in MNs and knock-out of telomerase reverse transcriptase in NPCs increased their
147 g the catalytic subunit of telomerase (human telomerase reverse transcriptase) in primary human mamma
148 sentation of a universal self-tumor antigen, telomerase reverse transcriptase, in human tumor cells d
149  be mediated through POT1/TRF2 and via human telomerase reverse transcriptase inhibition through JNK
150       The telomerase protein component TERT (telomerase reverse transcriptase) interacts with BRG1 (a
151                             The template for telomerase reverse transcriptase is within the RNA subun
152 the gene encoding its catalytic subunit, the telomerase reverse transcriptase, is established as the
153                             hTERT, the human telomerase reverse transcriptase, is highly expressed in
154 s well as the effect that over-expression of telomerase reverse transcriptase may have on the replica
155 ted the 3-prime untranslated region of human telomerase reverse transcriptase mRNA and decreased its
156                  HIF is sufficient to induce telomerase reverse transcriptase mRNA and telomerase act
157 ability of 1,25(OH)(2)D(3) to decrease human telomerase reverse transcriptase mRNA and to suppress ov
158 f IRF-4 results in decreased levels of TERT (telomerase reverse transcriptase) mRNA and telomerase ac
159 s and in carcinoma progression, an inducible telomerase reverse transcriptase (mTert) allele was cros
160 ation of slowly cycling ISCs marked by mouse telomerase reverse transcriptase (mTert) expression that
161 tation and telomere dysfunction [produced by telomerase reverse transcriptase (mTERT) gene knockout].
162                                   The enzyme telomerase reverse transcriptase (mTert) regulates telom
163 ein (GFP), driven by the promoter for murine telomerase reverse transcriptase (mTert), which is a nec
164                 We therefore generated mouse telomerase reverse transcriptase (mTert)-GFP-transgenic
165                      Here, we uncovered that telomerase reverse transcriptase null (Tert(-/-)) mESCs
166 oding a 4-hydroxytamoxifen (4-OHT)-inducible telomerase reverse transcriptase-oestrogen receptor (TER
167                CRISPR/Cas9 knockout of human telomerase reverse transcriptase or treatment with the t
168 perature-sensitive large T antigen and human telomerase reverse transcriptase (OSEtsT/hTERT).
169 of four genetic alterations, including human telomerase reverse transcriptase overexpression, bypass
170 Myc E-box-mediated transactivation and human telomerase reverse transcriptase promoter activity, in a
171 em TTS (TTF1 gene under the control of human telomerase reverse transcriptase promoter and human surf
172 te that Pyk2 is capable of driving the human telomerase reverse transcriptase promoter, resulting in
173 telomerase domain-complementation assays for telomerase reverse transcriptase protein (TERT) and RNA
174 s of two essential components, the catalytic telomerase reverse transcriptase protein (TERT) and the
175 te within its integral RNA subunit (hTR) and telomerase reverse transcriptase protein (TERT) to accom
176                                          The telomerase reverse transcriptase protein TERT has recent
177 erves to repress the production of the human telomerase reverse transcriptase protein.
178  to assemble telomerase enzymes with variant telomerase reverse transcriptase proteins.
179                              The specialized telomerase reverse transcriptase requires a multidomain
180                      The expression of human telomerase reverse transcriptase restored telomerase act
181                Using Chlamydomonas and human telomerase reverse transcriptase-retinal pigment epithel
182 of 5-MeCITP bound to the Tribolium castaneum telomerase reverse transcriptase reveals an atypical int
183               Subsequently, annealing of the telomerase reverse transcriptase RNA-template (guide RNA
184 rentiation family), catalytic subunit of rat telomerase reverse transcriptase (rTERT), and proliferat
185 studies utilizing a combination of BRCA1 and telomerase reverse transcriptase small interfering RNAs
186 e first characterize the gene coding for the telomerase reverse transcriptase subunit PpTERT in P. pa
187 d advantages of the TRAIL gene and the human telomerase reverse transcriptase target, Ad/gTRAIL can b
188 to telomeres through an association with the telomerase reverse transcriptase TERT.
189  HCC, the most frequently mutated genes were telomerase reverse transcriptase (TERT) (58.1%), catenin
190 onucleoprotein telomerase, which comprises a telomerase reverse transcriptase (TERT) and a telomerase
191 ng telomeric repeats using an active site in telomerase reverse transcriptase (TERT) and an integral
192 elomerase, a ribonucleoprotein consisting of telomerase reverse transcriptase (TERT) and an integrall
193          DNA-interacting subunits other than telomerase reverse transcriptase (TERT) and telomerase R
194 ns two essential components for catalysis, a telomerase reverse transcriptase (TERT) and telomerase R
195                                              Telomerase reverse transcriptase (TERT) and telomerase R
196                                              Telomerase reverse transcriptase (TERT) and telomerase R
197 critical for catalytic activity, the protein telomerase reverse transcriptase (TERT) and telomerase R
198 Telomerase minimally comprises the catalytic telomerase reverse transcriptase (TERT) and telomerase R
199      Telomerase contains a catalytic core of telomerase reverse transcriptase (TERT) and telomerase R
200              Mutations in the genes encoding telomerase reverse transcriptase (TERT) and telomerase's
201 ' ends of linear chromosomes, using a unique telomerase reverse transcriptase (TERT) and template in
202 ex, the catalytic core of which includes the telomerase reverse transcriptase (TERT) and the non-codi
203 mally consisting of a protein subunit called telomerase reverse transcriptase (TERT) and the telomera
204 ic mutations in the promoter of the gene for telomerase reverse transcriptase (TERT) are the most com
205 telomerase complex is influenced more by the telomerase reverse transcriptase (TERT) binding of the C
206 ls immortalized by the ectopic expression of telomerase reverse transcriptase (TERT) can give rise to
207 nt insights to the noncanonical functions of telomerase reverse transcriptase (TERT) catalytic subuni
208 ve suggested that the core protein mammalian telomerase reverse transcriptase (TERT) component, toget
209                                              Telomerase reverse transcriptase (TERT) confers the cata
210                   Differential regulation of telomerase reverse transcriptase (TERT) contributes to t
211 To perform DNA synthesis, the active site of telomerase reverse transcriptase (TERT) copies a templat
212 omerase RNA template, the active site in the telomerase reverse transcriptase (TERT) core, a TERT N-t
213 lete single-repeat synthesis requires only a telomerase reverse transcriptase (TERT) core.
214 in lung fibrosis, we examined the effects of telomerase reverse transcriptase (TERT) deficiency in a
215  the overexpression of myocardin (MYOCD) and telomerase reverse transcriptase (TERT) enhanced the sur
216                              Reactivation of telomerase reverse transcriptase (TERT) expression enabl
217                              Reactivation of telomerase reverse transcriptase (TERT) expression is fo
218 been previously shown that expression of the telomerase reverse transcriptase (TERT) gene extends the
219 ating mutations occur in the promoter of the telomerase reverse transcriptase (TERT) gene in 66% of m
220 , and point mutations in the promoter of the telomerase reverse transcriptase (TERT) gene increase te
221 ure in MYCN nonamplified neuroblastomas with telomerase reverse transcriptase (TERT) gene overexpress
222 is of B-cell lymphoma DNA confirmed that the telomerase reverse transcriptase (TERT) gene promoter is
223                       Point mutations in the telomerase reverse transcriptase (TERT) gene promoter oc
224  risk and rs2242652 at 5p15, intronic in the telomerase reverse transcriptase (TERT) gene that encode
225  find a germline deletion in intron 3 of the telomerase reverse transcriptase (TERT) gene that predis
226 tudy, the role of Smad3 in the inhibition of telomerase reverse transcriptase (TERT) gene transcripti
227 ty is characterized by the expression of the telomerase reverse transcriptase (TERT) gene, suggesting
228                   Differential regulation of telomerase reverse transcriptase (TERT) genes contribute
229 ed variants of human telomerase RNA (hTR) or telomerase reverse transcriptase (TERT) have exploited i
230 his study, we extend these observations into telomerase reverse transcriptase (TERT) immortalized ora
231 somatic acquisition of promoter mutations in telomerase reverse transcriptase (TERT) in blood leukocy
232 mplate boundary definition and high affinity telomerase reverse transcriptase (TERT) interaction.
233                                              Telomerase reverse transcriptase (TERT) is an essential
234                                      Because telomerase reverse transcriptase (TERT) is usually the l
235                                   Similarly, telomerase reverse transcriptase (tert) mutant zebrafish
236 ue activity in the catalytic protein subunit telomerase reverse transcriptase (TERT) of telomerase.
237 e downstream network in mice null for either telomerase reverse transcriptase (Tert) or telomerase RN
238 arrow carrying heterozygous mutations in the telomerase reverse transcriptase (TERT) or the telomeras
239 nations of defined tumor-expressed antigens, telomerase reverse transcriptase (TERT) or TRP-2, and VE
240 ct somatic single-nucleotide variants in the telomerase reverse transcriptase (TERT) promoter and iso
241                       Mutations in the human telomerase reverse transcriptase (TERT) promoter are the
242       We aimed to evaluate the occurrence of telomerase reverse transcriptase (TERT) promoter mutatio
243                                          The telomerase reverse transcriptase (TERT) promoter, an imp
244                          Integrations in the telomerase reverse transcriptase (TERT) promoter/enhance
245  genes, including MYC transactivation of the telomerase reverse transcriptase (TERT) promoter; and in
246 somes and consists of two main subunits: the telomerase reverse transcriptase (TERT) protein and an a
247 daka and fugu TRs, when assembled with their telomerase reverse transcriptase (TERT) protein counterp
248 ue TR-binding domain (TRBD) in the catalytic telomerase reverse transcriptase (TERT) protein, integra
249 teraction between the CR4-CR5 domain and the telomerase reverse transcriptase (TERT) protein.
250              Transcriptional reactivation of telomerase reverse transcriptase (TERT) reconstitutes te
251 of telomerase-associated proteins other than telomerase reverse transcriptase (TERT) remain ambiguous
252                                  Here, using telomerase reverse transcriptase (Tert) reporter mice, w
253 activity by repressing the catalytic subunit telomerase reverse transcriptase (TERT) through negative
254 determined structures of Tribolium castaneum telomerase reverse transcriptase (TERT) throughout its c
255 e that facilitates the subsequent binding of telomerase reverse transcriptase (TERT) to TER.
256 ize telomeric repeats, the catalytic subunit telomerase reverse transcriptase (TERT) uses the RNA sub
257 novel alternatively spliced (AS) variants of telomerase reverse transcriptase (TERT) were identified,
258 ver, tumorigenesis-associated genes IGF2 and telomerase reverse transcriptase (TERT) were overexpress
259 vitro with only the telomerase RNA (hTR) and telomerase reverse transcriptase (TERT), additional comp
260 -occurrence of mutations in the promoter for telomerase reverse transcriptase (TERT), along with BRAF
261 on of the catalytic component of telomerase, telomerase reverse transcriptase (TERT), alters sensitiv
262 s a ternary complex of telomerase RNA (TER), telomerase reverse transcriptase (TERT), and the essenti
263 ase RNA and a catalytic protein subunit, the telomerase reverse transcriptase (TERT), as well as seve
264  to mutations in the same genes, such as the telomerase reverse transcriptase (TERT), but through dif
265  RNA (TR) or the catalytic protein component telomerase reverse transcriptase (TERT), cause the genet
266   Regulator of telomere length-1 (RTEL1) and telomerase reverse transcriptase (TERT), genes involved
267 P. tetraurelia telomerase catalytic subunit, telomerase reverse transcriptase (TERT), has been cloned
268 s required for telomere maintenance, such as telomerase reverse transcriptase (TERT), have been found
269      Remarkably, with only binding sites for telomerase reverse transcriptase (TERT), minimized hTR a
270 ically organized by the components, i.e. the telomerase reverse transcriptase (TERT), telomerase RNA
271  often determined by the expression level of telomerase reverse transcriptase (TERT), the catalytic s
272 s exhibiting dysregulated growth may express telomerase reverse transcriptase (TERT), the dual functi
273 endent mutations within the core promoter of telomerase reverse transcriptase (TERT), the gene coding
274 omponents have been identified thus far: the telomerase reverse transcriptase (TERT), the telomerase
275 g an internal RNA template and a specialized telomerase reverse transcriptase (TERT), thereby maintai
276 on of the catalytic component of telomerase, telomerase reverse transcriptase (Tert), which is essent
277           Among 6,835 cancers, 73% expressed telomerase reverse transcriptase (TERT), which was assoc
278 riven by the transcriptional upregulation of telomerase reverse transcriptase (TERT).
279 onents, the telomerase RNA template (TR) and telomerase reverse transcriptase (TERT).
280 s using an integral telomerase RNA (TER) and telomerase reverse transcriptase (TERT).
281 , using an integral telomerase RNA (TER) and telomerase reverse transcriptase (TERT).
282      Cancer cells depend on transcription of telomerase reverse transcriptase (TERT).
283 chanistically, ASA treatment upregulates the telomerase reverse transcriptase (TERT)/Wnt/beta-catenin
284 an stem and cancer cells express telomerase [telomerase reverse transcriptase (TERT)] in an effort to
285     Furthermore, an evident up-regulation of telomerase reverse-transcriptase (TERT) expression was d
286 ted the expression of the catalytic subunit (telomerase reverse transcriptase [TERT]) but had no effe
287 ted RNA subunit and a reverse transcriptase (telomerase reverse transcriptase [TERT]).
288 , called motif 3, in the catalytic domain of telomerase reverse transcriptase, that is crucial for te
289 east three principal subunits, including the telomerase reverse transcriptase, the telomerase RNA (TE
290 alter the overall stability or expression of telomerase reverse transcriptase, these rare genetic dis
291 NA, which in turn directs the binding of the telomerase reverse transcriptase to form the functional
292                                              Telomerase reverse transcriptase (TRT) is a tumor-associ
293 ked with a homology model of the Tetrahymena telomerase reverse transcriptase (tTERT) to characterize
294 sing tissue reconstruction techniques; human telomerase reverse transcriptase was required for cells
295                       The catalytic subunit, telomerase reverse transcriptase, was expressed in human
296 ficient mutations in TERT, the gene encoding telomerase reverse transcriptase, we asked whether resto
297 xpressed c-kit, interleukin-31 receptor, and telomerase reverse transcriptase when compared with cont
298        Furthermore, recombinant AREG induced telomerase reverse transcriptase, which appeared to be e
299 amplicon and also encompasses TERT, encoding telomerase reverse transcriptase, which plays a critical
300                                 TERT encodes telomerase reverse transcriptase, which together with th

 
Page Top